NCFG
JAZZ icon

New Century Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

New Century Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,125
Closed -$388K – 131
2025
Q1 		$388K Buy
+3,125
New +$408K 0.45% 76

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

New Century Financial Group's JAZZ Position: Q2 2025 in Review

New Century Financial Group sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 3,125 shares — an estimated $388K sold.

New Century Financial Group first reported a position in JAZZ in Q1 2025 and held it in 1 quarter. The position peaked at $388K in Q1 2025. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • New Century Financial Group reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New Century Financial Group sold 3,125 Jazz Pharmaceuticals shares in Q2 2025, an estimated $388K.
  • New Century Financial Group first reported a position in Jazz Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • New Century Financial Group's Jazz Pharmaceuticals position peaked at $388K in Q1 2025.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on New Century Financial Group's 13F filing for Q2 2025, filed 21 Jul 2025.